Cell & Gene Therapy Manufacturing & Commercialization US Post Event Report (Gate)

Cell & Gene Therapy Manufacturing & Commercialization US 2021 Post-event ReportWe gather highlights from Cell and Gene Therapy Manufacturing & Commercialization US 2021 in its first time as a hybrid conference.Contents

Introduction

In September 2021, Cell and Gene Therapy Manufacturing & Commercialization US returned for the first time as a hybrid conference.

Co-located with BioProcess International, the event spanned across seven days, welcoming audiences in Boston and online, with tracks exploring:

Cell Therapy
Gene Edited Ex Vivo Cell Therapy
In Vivo Gene Therapy
Partnering & Collaborations
Tissue Engineering

In this post-event report in association with Avantor, we gather a collection of highlights from the week, including top presentations, a key panel discussion, poster and a spotlight session to watch on demand.

Jump to any article using the contents on the following page, or at any time using the Contents menu in the top left. There you can also download this report as a PDF.